Brevan Howard Reduces CME Group Stake by 39.6%

Hedge fund sells 69,136 shares of the financial services provider in Q3

Mar. 15, 2026 at 10:57am

Got story updates? Submit your updates here. ›

Brevan Howard Capital Management LP decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 39.6% in the 3rd quarter, according to the company's recent disclosure with the Securities and Exchange Commission. The institutional investor owned 105,580 shares of the financial services provider's stock after selling 69,136 shares.

Why it matters

CME Group operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), and the New York Mercantile Exchange (NYMEX). The company's core services include electronic trading, central clearing, and market data distribution. Brevan Howard's reduced stake in CME Group may signal a shift in the hedge fund's investment strategy or outlook on the financial services sector.

The details

According to the SEC filing, Brevan Howard Capital Management LP's holdings in CME Group were worth $28,527,000 as of the end of the 3rd quarter. The hedge fund's stake in the company represented approximately 0.1% of its total investment portfolio. The sale of 69,136 shares resulted in a 39.6% decrease in Brevan Howard's position in CME Group.

  • Brevan Howard decreased its CME Group holdings in the 3rd quarter of 2026.

The players

Brevan Howard Capital Management LP

An institutional investor and hedge fund that decreased its stake in CME Group by 39.6% in the 3rd quarter of 2026.

CME Group Inc.

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), and the New York Mercantile Exchange (NYMEX).

Got photos? Submit your photos here. ›

The takeaway

Brevan Howard's reduced stake in CME Group may signal a shift in the hedge fund's investment strategy or outlook on the financial services sector, though the reasons behind the sale are not explicitly stated. CME Group continues to be a major player in the global derivatives market, but investors will be watching to see if other institutional holders make similar moves in the coming quarters.